Samantha Garbers, Jada Murray, Sanketh Udupa, Jennifer L Evans
Oral contraceptives are widely used in the US, but prescription requirements are an access barrier, particularly for adolescents and young adults. Over-the-counter availability of norgestrel 0.075 mg (OPill) was anticipated to improve contraceptive access. This cross-sectional study assessed OPill availability in 17 Boston zip codes, stratified by Social Vulnerability Index (SVI). Among 33 pharmacies, 75.8% presented at least one barrier to access. OPill was available in all stores in low-SVI neighborhoods but not stocked in 13.6% of pharmacies in high-SVI neighborhoods, compounding low access to resources including healthcare. These findings underscore the gap between regulatory approval and equitable real-world contraceptive access.